Skip to main content

Godshall Douglas Evan's Form 4 filing

Shockwave Medical, Inc.SWAV · filed Aug 20, 2021

Accession no.
0000950103-21-012690
Filed
Aug 20, 2021
Trade date
Aug 18, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.46M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Godshall Douglas EvanCIK 0001404227Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2021Common StockMOption exerciseAcquired+45,000$3.42+$153,900181,856Direct
Aug 18, 2021Common StockSSaleDisposed−1,700$183.89F2−$312,613180,156Direct
Aug 18, 2021Common StockSSaleDisposed−1,700$184.72F3−$314,024178,456Direct
Aug 18, 2021Common StockSSaleDisposed−1,359$185.52F4−$252,121.68177,097Direct
Aug 18, 2021Common StockSSaleDisposed−8,273$186.86F5−$1,545,892.78168,824Direct
Aug 18, 2021Common StockSSaleDisposed−12,274$187.69F6−$2,303,707.06156,550Direct
Aug 18, 2021Common StockSSaleDisposed−7,212$188.84F7−$1,361,914.08149,338Direct
Aug 18, 2021Common StockSSaleDisposed−7,882$189.67F8−$1,494,978.94141,456Direct
Aug 18, 2021Common StockSSaleDisposed−3,500$190.66F9−$667,310137,956Direct
Aug 18, 2021Common StockSSaleDisposed−1,100$191.73F10−$210,903136,856Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 18, 2021Common StockMOption exerciseDisposed−45,000$0.00$0546,804Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $183.07 to $184.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $184.14 to $185.13. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $185.18 to $186.17. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $186.21 to $187.16. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $187.26 to $188.23. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $188.27 to $189.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $189.28 to $190.21. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $190.31 to $191.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $191.35 to $192.13. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)